Polyhydroxycarboxylates (MW 3800–14000) derived from phenolic (PDP) compounds were found to be selective inhibitors of human cytomegalovirus (CMV), herpes simplex virus type 1 (HSV-1), type 2 (HSV-2), thymidine kinase-deficient (TK−) HSV-1 and vaccinia virus replication at concentrations that are not toxic to the host cells. The PDP compounds were not inhibitory to parainfluenza virus, reovirus, Sindbis virus, or Semliki forest virus. The polycarboxylate aurintricarboxylic acid (ATA) (MW 1149–3336) also proved inhibitory to CMV and HSV replication. The anti-CMV and anti-HSV activities of the ATA polymers increased with increasing molecular weight. The mechanism of anti-CMV activity of both the PDP and ATA series of compounds can be attributed to the inhibition of virion attachment to the cells, probably due to an interaction of these polyanionic compounds with the positively charged domains of the viral envelope glycoproteins.
References
1.
BabaM.SnoeckR.PauwelsR., and De ClercqE. (1988a) Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother32: 1742–1745.
2.
BabaM.NakajimaM.ScholsD.PauwelsR.BalzariniJ., and De ClercqE. (1988b) Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Res9: 335–343.
3.
BabaM.PauwelsR.BalzariniJ.ArnoutJ.DesmyterJ., and De ClercqE. (1988c) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA85: 6132–6136.
4.
BabaM.ScholsD.De ClercqE.PauwelsR.NagyM.Györgyi-EdélenyiJ.LowM., and GörögS. (1990) Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Antimicrob Agents Chemother34: 134–138.
5.
BalzariniJ.MitsuyaH.De ClercqE., and BroderS. (1986) Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochem Biophys Res Commun136: 64–71.
6.
BrittW.J.PassR.F.StagnoS., and AlfordC.A. (1991) Pediatric cytomegalovirus infection. Transplantation Proc23: 115–117.
7.
CallahanL.PhelanM.MallisonM., and NorcrossM. (1991) Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J Virol65: 1543–1550.
8.
CushmanM.WangP.ChangS.H.WildC.De ClercqE.ScholsD.GoldmanM., and BowenJ.A. (1991a) Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. J Med Chem34: 329–339.
9.
CushmanM.KanamathareddyS.De ClercqE.ScholsD.GoldmanM., and BowenJ.A. (1991b) Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds. J Med Chem34: 337–342.
10.
De ClercqE.DescampsJ.VerfielstG.WalkerR.T.JonesA.S.TorrenceP.F., and ShugarD. (1980) Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis141: 563–574.
11.
De ClercqE.CoolsM.BalzariniJ.MarquezV.E.BorcherdingD.R.BorchardtR.T.DrachJ.C.KitaokaS., and KonnoT. (1989) Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A and their 5′-nor derivatives. Antimicrob Agents Chemother33: 1291–1297.
12.
EichhornU.KlöckingR., and HelbigB. (1984) Anwendung von 51Cr-markierten FL-Zellen zur Testung der antiviralen Aktivität von Phenolkörperpolymerisaten gegen Coxsackieviren in vitro. Dtsch Gesundh-Wesen39: 1514–1519.
13.
EmanuelD. (1990) Treatment of cytomegalovirus disease. Seminars in Hematology272, Suppl. 1: 22–27.
14.
HänninenK.KlöckingR., and HelbigB. (1987) Synthesis and characterization of humic acid-like polymers. The Science of the Total Environment62: 201–210.
15.
HeraldB.C.WuDunnD.SoltysN., and SpearP. (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol65: 1090–1098.
16.
HillsJ.MayA.SperberM.KlöckingR.HelbigB., and SprössigM. (1986) Hemmung ausgewählter Influenzavirusstämme der Typen A and B durch Phenolkörperpolymerisate. Biomed Biochim Acta45: 1173–1179.
17.
ItoM.BabaM.SatoR.PauwelsR.De ClercqE., and ShigetaS. (1989) Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res7: 361–367.
18.
KlöckingR., and HelbigB. (1991) Interaction of humic acids and humic acid-like polymers with herpes simplex virus type 1. In: Humic Substances in the Aquatic and Terrestrial Environment. AllardB.BorénH., and GrinvallA., (eds). Berlin: Springer-Verlag, pp. 407–412.
19.
NeytsJ.SnoeckR.ScholsD.BalzariniJ., and De ClercqE. (1990) Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG). Virology179: 41–50.
20.
NeytsJ.SnoeckR.BalzariniJ., and De ClercqE. (1991a) Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vitro. Antiviral Res16: 41–52.
21.
NeytsJ.SnoeckR.ScholsD.HimpensB., and De ClercqE. (1991b) Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents. J Virol Methods35: 27–38.
22.
NeytsJ.BalzariniJ.NaesensL., and De ClercqE. (1992a) Efficacy of (S)-(1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) and 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) in the treatment of murine cytomegalovirus infections in severe combined immunodeficiency (SCID) mice. J Med Virol, in press.
23.
NeytsJ.SnoeckR.ScholsD.BalzariniJ.EskoJ.D.Van SchepdaelA., and De ClercqE. (1992b) Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology189: in press.
24.
ScholsD.SnoeckR.NeytsJ., and De ClercqE. (1989a) Detection of immediate early, early and late antigens of human cytomegalovirus by flow cytometry. J Virol Methods26: 247–254.
25.
ScholsD.BabaM.PauwelsR.DesmyterJ., and De ClercqE. (1989b) Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc Natl Acad Sci USA86: 3322–3326.
26.
ScholsD.De ClercqE.BalzariniJ.BabaM.WitvrouwM.HosoyaM.AndreiG.SnoeckR.NeytsJ.PauwelsR.NagyM.Györgyi-EdélenyiJ.MachovichR.HorvárthI.LowM., and GörögS. (1990a) Sulfated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena- and retroviruses. Antiviral Chem Chemother1: 223–240.
27.
ScholsD.PauwelsR.DesmyterJ., and De ClercqE. (1990b) Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoproteins expressed by T-cells persistently infected with HIV-1. Virology175: 556–561.
28.
ScholsD.De ClercqE.WitvrouwM.NakashimaH.SnoeckR.Van SchepdaelA., and ClaesP. (1991a) Sulfated cyclodextrins are potent anti-HIV agents acting synergistically with 2′,3′-dideoxynucleoside analogues. Antiviral Chem Chemother2: 45–53.
29.
ScholsD.WutzlerP.KlöckingR.HelbigB., and De ClercqE. (1991b) Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication. J Acquir Immun Defic Syndr4: 677–684.
30.
ShiehM.-T.WuDunnD.MontgomeryR.I.EskoJ.D., and SpearP.G. (1992) Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol, 116: 1273–1281.
31.
SnoeckR.SakumaT.DeClercqE.RosenbergI., and HolyA. (1988) (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Antimicrob Agents Chemother32: 1839–1844.
32.
StagnoS.PassR.F.DworskyM.E.HendersonR.E.MooreE.G.WaltonP.D., and AlfordC.D. (1982) Congenital cytomegalovirus infections: the relative importance of primary and recurrent maternal infections. New Engl J Med306: 945–949.
33.
SydowG.WunderlichV.KlöckingR., and HeibigB. (1986) Zur Wirkung von Phenolkörperpolymerisaten auf Retroviren. Pharmazie41: 865–868.
34.
TymsA.S.TaylorD.L., and ParkinJ.M. (1989) Cytomegalovirus and the acquired immunodeficiency syndrome. J Antimicrob Chemother23, Suppl. A: 89–105.
35.
VerheydenJ.P.H. (1988) Evolution of therapy for cytomegalovirus infection. Rev Infect Dis10, Suppl. 3: S477–S489.
36.
WuDunnD., and SpearP.G. (1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol63: 52–58.
